http://hl7.eu/fhir/ig/gravitate-health/Bundle/bundlepackageleaflet-en-a64c0ccb066e7fdf6ba2d86dcd8bda5e
type: Bundle
node role: treeRoot
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi
    l: Bundle-uv-epi
language:
  v: en
identifier:
  system:
    v: https://www.gravitatehealth.eu/sid/doc
    l: doc
  value:
    v: gh-1
type:
  v: document
timestamp:
  v: 2023-06-27T10:09:22Z
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-04c5df8b1b688f62331c672bbd9ffa97
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-calchichewd3f-calciumcarbonate
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-calchichewd3f-cholecalciferol
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationa64c0ccb066e7fdf6ba2d86dcd8bda5e0
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-d21dfe8c15312e8b8bf0b7774b510a9d
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-a46ff5cb1a9568d59a1669fd597f58bf
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/MedicinalProductDefinition/mp04c5df8b1b688f62331c672bbd9ffa97
    l: mp04c5df8b1b688f62331c672bbd9ffa97
  resource: mp04c5df8b1b688f62331c672bbd9ffa97
entry:
  full url:
    v: http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e

http://hl7.eu/fhir/ig/gravitate-health/Composition/composition-en-04c5df8b1b688f62331c672bbd9ffa97
type: Composition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi
    l: Composition-uv-epi
language:
  v: en
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Composition composition-en-04c5df8b1b688f62331c672bbd9ffa97 Language: en Profile: Composition (ePI) identifier: https://spor.ema.europa.eu/rmswi//462b3fc5470f43286799c472a0c8554e status: Final type: Package Leaflet category: Raw date: 2022-02-16 13:28:17+0000 author: Organization Neon Healthcare Ltd title: TEST PURPOSES ONLY - Calcichew-D3 Forte Attesters - Mode Time * Official 2022-02-16 13:28:17+0000
identifier:
  system:
    v: https://spor.ema.europa.eu/rmswi/
    l: rmswi
status:
  v: final
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi/
      l: rmswi
    code:
      v: 100000155538
  text:
    v: Package Leaflet
category:
  coding:
    system:
      v: http://hl7.eu/fhir/ig/gravitate-health/CodeSystem/epicategory-cs
      l: epicategory-cs
    code:
      v: R
    display:
      v: Raw
subject:
  l: mp04c5df8b1b688f62331c672bbd9ffa97
date:
  v: 2022-02-16T13:28:17Z
title:
  v: TEST PURPOSES ONLY - Calcichew-D3 Forte
attester:
  mode:
    coding:
      system:
        v: http://hl7.org/fhir/composition-attestation-mode
        l: composition-attestation-mode
      code:
        v: official
  time:
    v: 2022-02-16T13:28:17Z
section:
  title:
    v: B. Package Leaflet
  code:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi/
        l: rmswi
      code:
        v: 100000155538
    text:
      v: B. Package Leaflet
  text:
    status:
      v: additional
    div:
      v: unavailable
  empty reason:
    coding:
      system:
        v: http://terminology.hl7.org/CodeSystem/list-empty-reason
        l: list-empty-reason
      code:
        v: unavailable
  section:
    title:
      v: Package leaflet: Information for the user
    code:
      text:
        v: Package leaflet: Information for the user
    text:
      status:
        v: additional
      div:
        v: PATIENT INFORMATION LEAFLET CALCICHEW*-D3 FORTE 500 mg/400 IU CHEWABLE TABLETS calcium/colecalciferol Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Always take this medicine exactly as described in this leaflet or as your pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - You must talk to a doctor if you do not feel better or if you feel worse after two weeks. - If you get any side effects talk to your pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
  section:
    title:
      v: What is in this leaflet
    code:
      text:
        v: What is in this leaflet
    text:
      status:
        v: additional
      div:
        v: What is in this leaflet: 1. What Calcichew-D3 Forte is and what it is used for 2. What you need to know before you take Calcichew-D3 Forte 3. How to take Calcichew-D3 Forte 4. Possible side effects 5. How to store Calcichew-D3 Forte 6. Contents of the pack and other information
  section:
    title:
      v: 1. What Calcichew-D3 Forte is and what it is used for
    code:
      text:
        v: 1. What Calcichew-D3 Forte is and what it is used for
    text:
      status:
        v: additional
      div:
        v: WHAT CALCICHEW- D3 FORTE IS AND WHAT IT IS USED FOR Calcichew-D3 Forte Chewable Tablets are lemon flavoured chewable tablets containing calcium and vitamin D3 which are both important substances in bone formation. Both are found in the diet and vitamin D is also produced in the skin after exposure to the sun. Calcichew-D3 Forte is used to treat and prevent vitamin D/calcium deficiency, which may occur when your diet or lifestyle does not provide enough, or when body requirements are increased. This medicine may also be prescribed or recommended for certain bone conditions, for example osteoporosis, or during pregnancy.
  section:
    title:
      v: 2. What you need to know before you take Calcichew-D3 Forte
    code:
      text:
        v: 2. What you need to know before you take Calcichew-D3 Forte
    text:
      status:
        v: additional
      div:
        v: WHAT YOU NEED TO KNOW BEFORE YOU TAKE CALCICHEW- D3 FORTE Do not take Calcichew- D3 Forte if you: • are allergic to calcium, vitamin D, or any of the other ingredients of this medicine (listed in section 6) • have severe kidney problems • have a condition that causes excessive amounts of calcium in your blood or urine (hypercalcaemia or hypercalciuria) e.g. o renal (kidney) failure o cancer that has affected your bones • have excessive amounts of vitamin D in your blood • have kidney stones. Warnings and precautions Talk to your doctor or pharmacist before taking Calcichew- D3 Forte: • if you have osteoporosis (brittle bones) and are also unable to move around • if you are on long term treatment, especially if you are taking medicines for a heart disorder (cardiac glycosides), or diuretics (used in the treatment of high blood pressure or oedema) • if you have signs of impaired kidney function or a high tendency to kidney stone (calculus) formation • if you have cancer or any other conditions that may have affected your bones • if you have sarcoidosis (an immune system disorder which may cause increased levels of vitamin D in the body). If you have any of the following conditions your serum calcium or phosphate levels, or urinary calcium excretion must be monitored. Calcichew should be taken under close medical supervision. • sarcoidosis (an immune system disorder which may affect your liver, lungs, skin or lymph nodes) • kidney problems • you are on long-term treatment with Calcichew • you are already taking additional doses of calcium or vitamin D. If you have increased calcium levels in the blood or develop signs of kidney problems, the dose of Calcichew-D3 Forte should be reduced or the treatment discontinued. Other medicines and Calcichew- D3 Forte Tell your pharmacist if you are taking, have recently taken or might take any other medicines. In particular, the following medicines may interact with Calcichew-D3 Forte chewable tablets: * thiazide diuretics (water …
  section:
    title:
      v: 3. How to take Calcichew-D3 Forte
    code:
      text:
        v: 3. How to take Calcichew-D3 Forte
    text:
      status:
        v: additional
      div:
        v: HOW TO TAKE CALCICHEW- D3 FORTE Always take Calcichew- D3 Forte Tablets exactly as described in this leaflet or as your pharmacist has told you. Check with your pharmacist if you are not sure. Dosage The recommended dose is two tablets a day, preferably one tablet in the morning and one tablet in the evening. The tablet may be chewed or sucked. Children Calcichew-D3 Forte chewable tablets are not recommended for use in children If you take more than you should If you have taken more Calcichew- D3 Forte than you should, talk to your pharmacist immediately. If you forget to take Calcichew- D3 Forte Chewable Tablets Do not take a double dose to make up for a forgotten tablet. If you have any further questions on the use of this medicine, ask your pharmacist.
  section:
    title:
      v: 4. Possible side effects
    code:
      text:
        v: 4. Possible side effects
    text:
      status:
        v: additional
      div:
        v: POSSIBLE SIDE EFFECTS Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop taking your medicine and see a doctor immediately if you experience: • Frequent urge to urinate * Headache • Loss of appetite, nausea or vomiting • Unusual tiredness or weakness, along with elevated levels of calcium in the blood and kidney impairment Side effects may include: Uncommon side effects (may affect up to 1 in 100 people): * excessive amounts of calcium in your blood (hypercalcaemia) or in your urine (hypercalcuria) may occur with large doses Rare side effects (may affect up to 1 in 1,000 people): * nausea * stomach ache * constipation * heartburn (dyspepsia) * diarrhoea * wind (flatulence) * rash * hives * itching Very rare side effects (may affect up to 1 in 10,000 people): * Milk alkali syndrome (also called Burnett’s Syndrome and usually only seen when excessive amounts of calcium have been ingested), symptoms are frequent urge to urinate, headache, loss of appetite, nausea or vomiting, unusual tiredness or weakness, along with elevated levels of calcium in the blood and kidney impairment. Not known (frequency cannot be estimated from the available data): * Hypersensitivity reactions such as swelling of the face, tongue, lips (angioedema) or swelling of the throat (laryngeal oedema). * If you have impaired renal function, you may be at risk of increased amounts of phosphate in the blood, renal stone formation and increased amounts of calcium in the kidneys. Reporting of side effects If you get any side effects, talk to your pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
  section:
    title:
      v: 5. How to store Calcichew-D3 Forte
    code:
      text:
        v: 5. How to store Calcichew-D3 Forte
    text:
      status:
        v: additional
      div:
        v: HOW TO STORE CALCICHEW-D3 FORTE Keep out of the sight and reach of children. Store in the original package. Keep the container tightly closed to protect from moisture. Do not store above 30°C Do not use Calcichew- D3 Forte Tablets after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month. If the tablets have changed shape or colour do not use. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
  section:
    title:
      v: 6. Contents of the pack and other information
    code:
      text:
        v: 6. Contents of the pack and other information
    text:
      status:
        v: additional
      div:
        v: CONTENTS OF THE PACK AND OTHER INFORMATION What Calcichew-D3 Forte Chewable Tablets contain The active ingredients in each tablet are: • 1250mg calcium carbonate (equivalent to 500mg calcium) • 400IU colecalciferol (equivalent to 10 micrograms vitamin D3) The other ingredients are: xylitol (E967), povidone, isomalt (E953), fatty acid mono- and di- glycerides, magnesium stearate, lemon flavour, sucralose (E955), sucrose, tocopherol, modified maize starch, medium-chain triglycerides, sodium ascorbate and anhydrous colloidal silica (see also end of Section 2 “Calcichew-D3 Forte contains isomalt and sucrose”). What Calcichew-D3 Forte look like and contents of the pack The tablets are round, white, uncoated, convex and lemon flavoured; they may have small specks. The tablets are packed in white, plastic bottles of 60 and 100 tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder Neon Healthcare Ltd., 8 The Chase, John Tate Road, Hertford, SG13 7NN, UK Manufacturer Asker Contract Manufacturing AS, Drammensveien 852, N-1385 Asker, Norway. This leaflet was last revised in March 2023. Additional Information Calcichew-D3 Forte are a combination of calcium and vitamin D designed to keep bones healthy. Calcium is an essential component of bones while vitamin D plays an important role in the absorption of calcium from food. Requirements for calcium increase with age and, although many people obtain enough calcium from their diet, some people may require a supplement in order that their body has all the calcium it needs to maintain healthy bones. Vitamin D is produced largely from the action of sunlight. Certain foodstuffs do contain vitamin D in reasonable amounts but it is not always possible to obtain all the vitamin D you need from your diet. People who do not get out and about, for instance those who are housebound or people living in nursing and residential homes, may not receive all the vitamin D they need. People with diets and lifestyles that mean th…

http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-calchichewd3f-calciumcarbonate
type: Ingredient
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-calchichewd3f-calciumcarbonate Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/H0G9379FGK (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#gh-1 (use: official, ); status = active; manufacturedDoseForm = Chewable tablet; unitOfPresentation = Tablet MedicinalProductDefinition: identifier = http://fakesys.com/ids#gh-1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#gh-1; status = active; administrableDoseForm = Chewable tablet; unitOfPresentation = Tablet role: Active substance Codes - Concept * Calcium Carbonate Strengths - Presentation[x] Basis * 2500 mg (Details: UCUM codemg = 'mg') active ingredient - basis of strength
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: H0G9379FGK
status:
  v: active
for:
  l: mp04c5df8b1b688f62331c672bbd9ffa97
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072072
    display:
      v: Active
substance:
  strength:
    presentation: Quantity
      value:
        v: 2500
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: mg

http://hl7.eu/fhir/ig/gravitate-health/Ingredient/ingredient-for-calchichewd3f-cholecalciferol
type: Ingredient
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi
    l: Ingredient-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Ingredient ingredient-for-calchichewd3f-cholecalciferol Profile: Ingredient (ePI) identifier: https://gsrs.ncats.nih.gov/ginas/app/beta/1C6V77QF41 (use: official, ) status: Active for: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#gh-1 (use: official, ); status = active; manufacturedDoseForm = Chewable tablet; unitOfPresentation = Tablet MedicinalProductDefinition: identifier = http://fakesys.com/ids#gh-1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription AdministrableProductDefinition: identifier = https://spor.ema.europa.eu/pmswi#gh-1; status = active; administrableDoseForm = Chewable tablet; unitOfPresentation = Tablet role: Active substance Codes - Concept * cholecalciferol Strengths - Presentation[x] Basis * 22 ug (Details: UCUM codeug = 'ug') active ingredient - basis of strength
identifier:
  use:
    v: official
  system:
    v: https://gsrs.ncats.nih.gov/ginas/app/beta
    l: beta
  value:
    v: 1C6V77QF41
status:
  v: active
for:
  l: mp04c5df8b1b688f62331c672bbd9ffa97
role:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072072
    display:
      v: Active
substance:
  strength:
    presentation: Quantity
      value:
        v: 22
      system:
        v: http://unitsofmeasure.org
        l: unitsofmeasure.org
      code:
        v: ug

http://hl7.eu/fhir/ig/gravitate-health/AdministrableProductDefinition/ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e
type: AdministrableProductDefinition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi
    l: AdministrableProductDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: AdministrableProductDefinition ap-a64c0ccb066e7fdf6ba2d86dcd8bda5e Profile: AdministrableProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/gh-1 status: Active formOf: MedicinalProductDefinition: identifier = http://fakesys.com/ids#gh-1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription administrableDoseForm: Chewable tablet unitOfPresentation: Tablet producedFrom: ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#gh-1 (use: official, ); status = active; manufacturedDoseForm = Chewable tablet; unitOfPresentation = Tablet routeOfAdministration code: Oral use TargetSpecies - Code * Human
identifier:
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: gh-1
status:
  v: active
form of:
  l: mp04c5df8b1b688f62331c672bbd9ffa97
administrable dose form:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000073684
    display:
      v: Chewable tablet
unit of presentation:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 200000002152
    display:
      v: Tablet
route of administration:
  code:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 100000073619
      display:
        v: Oral use

http://hl7.eu/fhir/ig/gravitate-health/RegulatedAuthorization/authorizationa64c0ccb066e7fdf6ba2d86dcd8bda5e0
type: RegulatedAuthorization
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi
    l: RegulatedAuthorization-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: RegulatedAuthorization authorizationa64c0ccb066e7fdf6ba2d86dcd8bda5e0 Profile: RegulatedAuthorization (ePI) identifier: https://spor.ema.europa.eu/pmswi/gh-1 (use: official, ) subject: MedicinalProductDefinition: identifier = http://fakesys.com/ids#gh-1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription type: Marketing Authorisation status: Active statusDate: 2015-02-07 13:28:17+0000 holder: Organization Neon Healthcare Ltd
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: gh-1
subject:
  l: mp04c5df8b1b688f62331c672bbd9ffa97
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 220000000061
    display:
      v: Marketing Authorisation
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: Active
status date:
  v: 2015-02-07T13:28:17Z

http://hl7.eu/fhir/ig/gravitate-health/Organization/mah-d21dfe8c15312e8b8bf0b7774b510a9d
type: Organization
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi
    l: Organization-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: Organization mah-d21dfe8c15312e8b8bf0b7774b510a9d Profile: Organization (ePI) identifier: https://spor.ema.europa.eu/omswi/xx (use: official, ) active: true type: Marketing authorisation holder name: Neon Healthcare Ltd Contacts - Address * 8 The Chase, John Tate Road, Foxholes Business Park, Hertford Hertfordshire UK(work)
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/omswi
    l: omswi
  value:
    v: xx
active:
  v: true
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 220000000034
    display:
      v: Marketing authorisation holder
name:
  v: Neon Healthcare Ltd
contact:
  address:
    use:
      v: work
    type:
      v: physical
    text:
      v: 8 The Chase, John Tate Road, Foxholes Business Park, Hertford Hertfordshire UK
    line:
      v: 8 The Chase, John Tate Road, Foxholes Business Park, Hertford
    city:
      v: Hertfordshire
    country:
      v: UK

http://hl7.eu/fhir/ig/gravitate-health/PackagedProductDefinition/ppd-a46ff5cb1a9568d59a1669fd597f58bf
type: PackagedProductDefinition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi
    l: PackagedProductDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: PackagedProductDefinition ppd-a46ff5cb1a9568d59a1669fd597f58bf Profile: PackagedProductDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/gh-1 (use: official, ) name: Calcichew-D3 Forte 28 type: Chemical Medicinal Product packageFor: MedicinalProductDefinition: identifier = http://fakesys.com/ids#gh-1; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription status: Active statusDate: 2015-02-07 13:28:17+0000 packaging type: Box quantity: 1 material: Cardboard packaging identifier: https://spor.ema.europa.eu/pmswi/123456 type: Blister quantity: 28 material: PolyVinyl Chloride containedItem Items - Reference * ManufacturedItemDefinition: identifier = https://spor.ema.europa.eu/pmswi#gh-1 (use: official, ); status = active; manufacturedDoseForm = Chewable tablet; unitOfPresentation = Tablet
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: gh-1
name:
  v: Calcichew-D3 Forte 28
type:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000155527
    display:
      v: Chemical Medicinal Product
package for:
  l: mp04c5df8b1b688f62331c672bbd9ffa97
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: Active
status date:
  v: 2015-02-07T13:28:17Z
packaging:
  type:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 100000073498
      display:
        v: Box
  quantity:
    v: 1
  material:
    coding:
      system:
        v: https://spor.ema.europa.eu/rmswi
        l: rmswi
      code:
        v: 200000003529
      display:
        v: Cardboard
  packaging:
    identifier:
      system:
        v: https://spor.ema.europa.eu/pmswi
        l: pmswi
      value:
        v: 123456
    quantity:
      v: 28

mp04c5df8b1b688f62331c672bbd9ffa97
type: MedicinalProductDefinition
id:
  v: mp04c5df8b1b688f62331c672bbd9ffa97
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi
    l: MedicinalProductDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: MedicinalProductDefinition mp04c5df8b1b688f62331c672bbd9ffa97 Profile: MedicinalProductDefinition (ePI) identifier: http://fakesys.com/ids/gh-1 type: Medicinal Product domain: Human use status: active legalStatusOfSupply: Medicinal product subject to medical prescription name productName: Calcichew-D3 Forte type: Full name part part: Calcichew-D3 Forte type: Invented name part part part: calcium/colecalciferol type: Scientific name part part part: 500 mg/400 IU type: Strength part part part: CHEWABLE TABLETS type: Pharmaceutical dose form part Usages - Country Jurisdiction Language * United Kingdom United Kingdom English
identifier:
  system:
    v: http://fakesys.com/ids
    l: ids
  value:
    v: gh-1
type:
  coding:
    system:
      v: http://hl7.org/fhir/medicinal-product-type
      l: medicinal-product-type
    code:
      v: MedicinalProduct
    display:
      v: Medicinal Product
domain:
  coding:
    system:
      v: http://hl7.org/fhir/medicinal-product-domain
      l: medicinal-product-domain
    code:
      v: Human
    display:
      v: Human use
status:
  coding:
    system:
      v: http://hl7.org/fhir/publication-status
      l: publication-status
    code:
      v: active
    display:
      v: active
legal status of supply:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 100000072084
    display:
      v: Medicinal product subject to medical prescription
name:
  product name:
    v: Calcichew-D3 Forte
  type:
    coding:
      system:
        v: https://spor.ema.europa.eu/lists/220000000000
        l: https://spor.ema.europa.eu/lists/220000000000
      code:
        v: 220000000001
      display:
        v: Full name
  part:
    part:
      v: Calcichew-D3 Forte
  part:
    part:
      v: calcium/colecalciferol
  part:
    part:
      v: 500 mg/400 IU
  part:
    part:
      v: CHEWABLE TABLETS

http://hl7.eu/fhir/ig/gravitate-health/ManufacturedItemDefinition/mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e
type: ManufacturedItemDefinition
meta:
  profile:
    v: http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi
    l: ManufacturedItemDefinition-uv-epi
text:
  status:
    v: generated
  div:
    v: Generated Narrative: ManufacturedItemDefinition mid-a64c0ccb066e7fdf6ba2d86dcd8bda5e Profile: ManufacturedItemDefinition (ePI) identifier: https://spor.ema.europa.eu/pmswi/gh-1 (use: official, ) status: Active manufacturedDoseForm: Chewable tablet unitOfPresentation: Tablet
identifier:
  use:
    v: official
  system:
    v: https://spor.ema.europa.eu/pmswi
    l: pmswi
  value:
    v: gh-1
status:
  v: active
manufactured dose form:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi/
      l: rmswi
    code:
      v: 100000073684
    display:
      v: Chewable tablet
unit of presentation:
  coding:
    system:
      v: https://spor.ema.europa.eu/rmswi
      l: rmswi
    code:
      v: 200000002152
    display:
      v: Tablet

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: 100000155538

v: H0G9379FGK

v: Calcium Carbonate

v: ACTIB

v: active ingredient - basis of strength

v: 1C6V77QF41

v: cholecalciferol

v: ACTIB

v: active ingredient - basis of strength

v: 100000109093

v: Human

v: 100000073496

v: Blister

v: 200000003222

v: PolyVinyl Chloride

v: 220000000002

v: Invented name part

v: 220000000003

v: Scientific name part

v: 220000000004

v: Strength part

v: 220000000005

v: Pharmaceutical dose form part

v: urn:iso:std:iso:3166
l: 3166

v: UK

v: United Kingdom

v: urn:iso:std:iso:3166
l: 3166

v: UK

v: United Kingdom

v: urn:ietf:bcp:47
l: 47

v: en

v: English